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Open Forum Infectious Diseases
MAJOR ARTICLE
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Background. Pre-exposure prophylaxis (PrEP) is an effective human immunodeficiency virus (HIV) prevention intervention,
but its access and use are suboptimal, especially for women. Healthcare providers provision of PrEP is a key component of the
Ending the HIV Epidemic initiative. Although training gaps are an identified barrier, evidence is lacking regarding how to tailor
trainings for successful implementation. Title X family planning clinics deliver safety net care for women and are potential PrEP
delivery sites. To inform provider training, we assessed PrEP knowledge, attitudes, and self-efficacy in the steps of PrEP care
among Title X providers in the Southern United States.
Methods. We used data from providers in clinics that did not currently provide PrEP from a web-based survey administered to
Title X clinic staff in 18 Southern states from February to June 2018. We developed generalized linear mixed models to evaluate
associations between provider-, clinic-, and county-level variables with provider knowledge, attitudes, and self-efficacy in PrEP
care, guided by the Consolidated Framework for Implementation Research.
Results. Among 351 providers from 193 clinics, 194 (55%) were nonprescribing and 157 (45%) were prescribing providers.
Provider ability to prescribe medications was significantly associated PrEP knowledge, attitudes, and self-efficacy. Self-efficacy
was lowest in the PrEP initiation step of PrEP care and was positively associated with PrEP attitudes, PrEP knowledge, and
contraception self-efficacy.
Conclusions. Our findings suggest that PrEP training gaps for family planning providers may be bridged by addressing
unfavorable PrEP attitudes, integrating PrEP and contraception training, tailoring training by prescribing ability, and focusing
on the initiation steps of PrEP care.
Keywords. HIV prevention; implementation science; PrEP; provider education; women’s health.

INTRODUCTION

The Southern United States has the highest burden of human
immunodeficiency virus (HIV) compared to other US regions
[1]. Women comprise 20% of the 40 000 annual new diagnoses,
the majority of whom live in the South [1, 2]. Human immuno
deficiency virus pre-exposure prophylaxis (PrEP) is a safe,
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effective, individual-controlled, and scalable HIV prevention
strategy that is a key initiative in the Department of Health
and Human Services (DHHS) “Ending the HIV Epidemic: A
Plan for America” [3, 4]. Despite national efforts for wide
spread PrEP dissemination, uptake remains disproportionately
low in in the South [1] and among women, only 10% of whom
who could benefit from PrEP were prescribed in 2019 [5–7].
The Ending the HIV Epidemic initiative emphasizes opti
mizing the HIV workforce through partnerships with diverse
organizations and healthcare provider training [4], which is a
necessary preimplementation step. However, few US PrEP im
plementation studies have focused on provider training needs
[8] or considered women’s health providers [9], who face key
challenges to scaling PrEP. Structural barriers include low riskperception and awareness of PrEP among women [10–13] and
scarcity of PrEP-providing clinics and insurance support for
PrEP, particularly in the South [5, 14, 15]. Provider-level barri
ers include variable knowledge and attitudes towards PrEP
Bridging PrEP Provider Training Gaps • OFID • 1
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Human Immunodeficiency Virus Pre-Exposure
Prophylaxis Knowledge, Attitudes, and Self-Efficacy
Among Family Planning Providers in the Southern United
States: Bridging the Gap in Provider Training

METHODS
Study Design and Population

The parent study’s protocol, recruitment strategies, data
collection instruments, and statistical analysis methods have
been previously described [23]. In brief, we conducted a
web-based, geographically targeted survey of healthcare
providers and clinic administrators from Title X clinics in 18
Southern states between February and June 2018 (DHHS
regions III [Mid-Atlantic: Washington DC, Delaware,
Maryland, Pennsylvania, Virginia, West Virginia], IV
[Southeast: Alabama, Florida, Georgia, Kentucky, Mississippi,
North Carolina, South Carolina, Tennessee], and VI
[Southwest: Arkansas, Louisiana, New Mexico, Oklahoma,
Texas]). Participants were recruited online through the
National Clinical Training Center for Family Planning
(NCTCFP), in-person at the NCTCFP meeting, and through
engagement with state Title X grantees. Surveys completed by
respondents outside of the designated Title X DHHS regions
were excluded (13 of 755), and only surveys in which the
2 • OFID • Ramakrishnan et al

participant responded to the question of PrEP use in the clinic
were included (n = 519). As part of evaluating clinic readiness
to implement PrEP [14], the parent survey addressed various
CFIR domains including Characteristics of Individuals, which
comprised the constructs of provider knowledge, attitudes,
and self-efficacy in PrEP care. The parent survey was created
so that only respondents from non-PrEP providing clinics
completed certain survey items; therefore, only non-PrEP pro
viding clinic providers (defined as any clinical staff who could
screen, counsel, or prescribe PrEP) were included in this anal
ysis. This methodology was aligned with our overarching goal
of understanding best practices for provider training to facili
tate PrEP delivery. Approval was obtained from the Emory
University and University of North Carolina Institutional
Review Boards.
Survey Measures

Measures were selected from the 93-item parent survey
[14, 23]. Survey items were adapted from existing measures
of CFIR constructs (ie, implementation climate, leadership en
gagement, PrEP knowledge, and PrEP attitudes) [17, 23–27] or
developed by the study team using CFIR-specific tools to assess
CFIR constructs relevant to PrEP implementation (ie, for selfefficacy) [21] (Supplemental Figure 1).
The primary outcomes of this analysis were the CFIR-guided
constructs of PrEP knowledge, PrEP attitudes, and self-efficacy
in PrEP care. Outcome measures were derived as semicontinu
ous composite scores based on collections of related survey
items. Survey items had high internal consistency based on
Cronbach’s Alpha [14]. Survey questions assessing knowledge
were based on a previously published survey of PrEP knowl
edge and attitudes among FP providers [17], and this consisted
of 5 multiple choice questions addressing PrEP medication
identification, efficacy in clinical trials, HIV testing, frequency
of monitoring patients taking PrEP, and frequency of monitor
ing side-effects and laboratories for patients taking PrEP. The
summary score for PrEP knowledge was derived as the mean
sum of correct responses (range, 0–5). Other CFIR-related sur
vey items were evaluated on a 5-point Likert scale (1 = strongly
disagree to 5 = strongly agree). Survey items addressing atti
tudes towards PrEP were divided topically into the following
subcategories: (1) “Acceptability of PrEP Integration in FP
Settings” and (2) “Clinical and Socio-behavioral Attitudes to
wards PrEP”. The summary score for PrEP attitudes was calcu
lated as the average of survey items (range, 0–5). Higher
Likert-scale scores for positively worded questions indicated
more favorable attitudes towards PrEP, and for negatively
worded questions they indicated more unfavorable attitudes
towards PrEP. Certain survey items were recoded for
the same directionality when deriving the overall score.
Self-efficacy was evaluated through survey questions on confi
dence in addressing each step of PrEP care: “PrEP Screening”
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among primary care providers, HIV clinicians, and family
planning (FP) providers [16–19]. Knowledge about PrEP and
likelihood of PrEP prescribing have also been found to be lower
among providers in the South compared to providers in other
regions [8, 16, 17, 20].
The Consolidated Framework for Implementation Research
(CFIR) [21] can be applied to assess factors that may influence
provider PrEP training and implementation. Within the CFIR
domain, “Characteristics of Individuals,” 3 key constructs rele
vant to PrEP training include the following: knowledge about
PrEP, attitudes towards PrEP, and self-efficacy in PrEP care
(ie, confidence in conducting the steps of PrEP care). The
Title X Family Planning Program provides funding to support
a diverse network of clinics that serve as a safety net source of
healthcare for women, particularly in areas without Medicaid
expansion [14], and are potential PrEP delivery sites. The diver
sity of Title X-funded clinics may lead to variable models of
PrEP care [22], thus tailoring trainings based on assessment
of these CFIR constructs may be particularly relevant for
PrEP scale-up in this setting. However, effective strategies to
improve provider provision of PrEP in women’s health settings
are unknown.
We recently conducted a CFIR-guided survey of providers
and administrators from Title X clinics in the South to sys
tematically study facilitators and barriers to implementation
of PrEP in this setting [14]. In this secondary analysis of the
parent survey, our objectives are to assess the associations be
tween provider-, clinic-, and county-level covariates, and the
CFIR constructs of provider knowledge, attitudes, and selfefficacy in PrEP care, with the overall goal of informing how
to tailor PrEP training for FP providers in the Southern
United States.

Statistical Analyses

Statistical analyses were performed using SAS version 9.4 (SAS
Software, Cary, NC). Variables were summarized with descrip
tive statistics (means [standard deviation {SD}] or counts [%]
for all providers and/or clinics where appropriate). We applied
χ2 and t tests, where appropriate, to compare PrEP knowledge,
attitudes, and self-efficacy scores between prescribing and non
prescribing providers. Paired t tests were applied to compare
mean scores between the self-efficacy steps of PrEP care.
We first used simple linear regression to evaluate associa
tions between each provider-, clinic-, and county-level covari
ate and each CFIR outcome. All covariates with P < .2 were
included in the multivariable models. Next, generalized linear
mixed models that included a clinic-specific random effect
were developed for each outcome. If covariates were collinear
(r > 0.8), then only 1 relevant covariate was retained. Log trans
formation was applied to covariates that did not have a normal
distribution. Backward selection was applied (threshold P < .2)

to develop reduced linear mixed models, which were compared
with the full models to assess consistency. Given potential het
erogeneity in provider experience based on prescribing, models
for each outcome were then stratified by prescriber status.
Missing data were uncommon and observations were dropped
from the models if data were incomplete. Analyses were re
stricted to respondents who responded to at least 1 survey
item pertaining to that outcome. Statistical tests were deemed
significant for P < .05.
Patient Consent Statement

Participant written consent was obtained, and design of this
work was approved by Emory University and University of
North Carolina Institutional Review Boards.
RESULTS

Overall, 519 providers and administrators from 283 unique
clinics completed the parent survey. After excluding responses
from administrators and those from PrEP providing clinics,
351 providers from 193 unique non-PrEP clinics were included
in this secondary analysis. The mean age was 45 (11.9%) years,
310 (88%) were female, and 228 (65%) were White (Table 1).
Providers had worked in their respective clinics for a mean du
ration of 8.1 (SD = 8.33) years, and 157 (45%) could prescribe
medications with or without supervision (prescribing provid
ers). Nonprescribing providers consisted of 131 (63%) nurses
and 65 (31%) other clinical staff (health educators, counselors,
medical assistants, or patient navigators).
Regarding clinic-level characteristics, 346 (70%) survey re
spondents were from the Southeast DHHS region, 244 (70%)
were from clinics located in metropolitan areas, and 279
(79%) were from clinics classified as health departments. One
hundred twenty-three (35%) respondents noted that their clin
ics provided primary care services, 227 (65%) endorsed that
their clinics had onsite insurance assistance, and 158 (45%) re
ported that their clinics had a pharmacy onsite. At the county
level, 113 (32%) respondents were from clinics located in catch
ment areas of Medicaid expansion. County HIV prevalence rate
was a median 290 per 100 000 population.
Knowledge About Pre-Exposure Prophylaxis

The mean sum of correct responses for knowledge survey items
(of 5) was 2.6 (SD = 1.72) and higher for prescribing versus
nonprescribing providers (P < .0001) (Supplemental Table 1).
Unadjusted associations between provider-, clinic-, and
county-level covariates and PrEP knowledge are shown in
Supplemental Table 2. In the overall adjusted model, PrEP
knowledge was positively associated with prescribing ability
(0.851; 95% confidence interval [CI], 0.493–1.209) and nega
tively associated with years worked in clinic role (−0.031;
95% CI: −.053 to −0.010) (Figure 1, Supplemental Table 3).
Bridging PrEP Provider Training Gaps • OFID • 3
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(comprising patient engagement and initial clinical evalua
tion), “PrEP Initiation”, and “PrEP Follow-up” [27, 28].
The summary score was calculated as the average of all selfefficacy survey items and subcategorized into these steps of
PrEP care.
Provider-, clinic-, and county-level characteristics were se
lected as covariates a priori based on review of the literature.
Provider-level covariates included age, gender (female vs oth
er), self-reported race (White vs non-White), ethnicity
(Latinx vs non-Latinx), years worked in clinic role, ability to
prescribe medication (yes with or without a supervisor vs
no), and “contraception self-efficacy”—the summary score of
5-point Likert survey items addressing confidence in conduct
ing family planning care (Table 2). Clinic-level covariates in
cluded clinic type (health department, federally qualified
health center, or other), onsite insurance assistance (yes vs
no), onsite pharmacy (yes vs no), and offering primary care ser
vices (yes vs no). County-level covariates for the population of
the clinic catchment area included HIV prevalence rate, per
centage uninsured, percentage living in poverty, percentage
with a high school degree, percentage Hispanic/Latinx, per
centage of reproductive-age females, Medicaid expansion (yes
vs no), and DHHS Title X region based on county-level
AIDSVu and Census data using the geocoded address of the
provider’s clinic [29, 30]. Because data from counties with a
small number of HIV cases and/or a small population size
are suppressed in AIDSVu, for analysis we recoded suppressed
values to the smallest positive HIV prevalence rate across the
dataset. Using the 2013 NCHS urban-rural classification
scheme, clinics were classified as metropolitan (ie, urban, in
cluding large central or fringe metro, medium metro, and small
metro areas) and nonmetropolitan (ie, rural, including micro
politan and noncore counties) [31].

Table 1. Provider-, Clinic-, and County-Level Characteristics of Survey Respondents From Title X Family Planning Clinics in the Southern United States
That Did Not Provide PrEP, by Ability to Prescribe Medications

Variable

All Providers
(n = 351)

Prescribing Providersa
(n = 157)

Nonprescribing Providersb
(n = 194)

45.32 (11.93)

47.2 (12.78)

43.71 (10.94)

Provider-Level Characteristics
Age (in Years), Mean (SD)
Gender, n (%)
3 (1.0)

0 (0)

3 (1.8)

310 (98.7)

142 (99.3)

168 (98.2)

Genderqueer

1 (0.3)

1 (0.7)

0 (0)

Nonbinary

0 (0)

0 (0)

0 (0)

Female

Ethnicity, n (%)
Latino/Latina/Latinx
Not Latino/Latina/Latinx

12 (3.9)

3 (2.2)

9 (5.3)

296 (96.1)

135 (97.8)

162 (94.7)

Race, n (%)
Asian/Pacific Islander
Black/African American
Native American/Alaskan Native
White
Other
More than 1 Race

6 (2.0)

4 (2.8)

2 (1.2)

57 (18.6)

19 (13.5)

38 (22.5)

1 (0.3)

4 (2.8)

1 (0.6)

228 (74.5)

111 (78.7)

117 (69.2)

3 (1.0)

0 (0)

3 (1.8)

3 (1.6)

8 (4.7)

11 (3.6)

Primary role(s) at clinicc n (%)
Clinical Provider (NP, CNM, PA, MD, DO)

157 (44.7)

157 (100)

Nurse

157 (44.7)

26 (16.6)

131 (67.5)

69 (19.7)

4 (2.5)

65 (33.5)

7 (2.0)

1 (0.6)

6 (3.1)

13 (3.7)

8 (5.1)

Health Educator, Counselor, Health Care

0 (0)

Associate, Medical Assistant, or Patient Navigator
Other Provider
Other Administrator
Years Worked in Clinic Role, Mean (SD)

5 (2.6)

8.12 (8.33)

8.46 (7.88)

7.85 (8.70)

Metropolitan

244 (69.5)

116 (73.9)

128 (66.0)

Nonmetropolitan

107 (30.5)

41 (26.1)

66 (34.0)

Yes

123 (35.0)

49 (31.2)

89 (45.9)

No

228 (65.0)

74 (38.1)

105 (54.1)

Yes

227 (64.7)

107 (68.2)

120 (61.9)

No/Unknown

124 (35.3)

50 (31.9)

74 (38.1)

Yes

158 (45.3)

69 (44.5)

89 (45.9)

No/Unknown

191 (54.7)

86 (55.5)

105 (54.1)

Clinic-Level Characteristics
Location, n (%)

Primary Care Services Provided at clinic, n (%)

Staff to Assist Patients Enrolling in Medicaid and
Insurance Programs, n (%)

Respondent’s Clinic has A Pharmacy on Site, n (%)

Clinic Type, n (%)
Family Planning

8 (2.3)

6 (3.8)

2 (1.0)

279 (79.7)

114 (72.6)

165 (85.5)

20 (5.7)

15 (9.6)

5 (2.6)

2 (0.6)

2 (1.3)

0 (0)

27 (7.7)

12 (7.6)

15 (7.8)

Community

7 (2.0)

4 (2.5)

3 (1.6)

School

5 (1.4)

3 (1.9)

2 (1.0)

Other

2 (0.6)

1 (0.6)

1 (0.5)

Health Department
Hospital
Planned Parenthood
Federally Qualified Health Center

Clinic Title x Region, n (%)
Region III (Mid-atlantic)

72 (20.5)

43 (27.4)

29 (15.0)

Region IV (Southeast)

246 (70.1)

97 (61.8)

149 (76.8)

Region VI (Southwest)

33 (9.4)

17 (10.8)

16 (8.3)

Yes

113 (32.2)

61 (38.9)

52 (26.8)

No

238 (67.8)

96 (61.2)

142 (73.2)

County-Level Characteristics
Medicaid Expansiond, n (%)
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Male

Table 1. Continued
All Providers
(n = 351)

Prescribing Providersa
(n = 157)

Nonprescribing Providersb
(n = 194)

HIV Prevalence Rate (Per 100 000 Population),
Median (IQR)

289.5 (351.0)

347.5 (397.5)

259.0 (365.0)

Reproductive-Age Women (15–44 Years) (%),
Mean (SD)

20.18 (3.12)

20.73 (3.57)

19.73 (2.60)

Variable

Hispanic or Latinx (%), Mean (SD)

5.90 (6.10)

5.50 (4.60)

68 (18.93)

69.68 (17.60)

66.66 (19.89)

Black Race (%), Mean (SD)

23.36 (18.61)

20.94 (16.85)

25.32 (19.75)

Uninsured (%), Mean (SD)

12.73 (3.42)

12.25 (3.62)

13.12 (3.20)

Living in Poverty (%), Mean (SD)

18.56 (5.18)

17.62 (5.29)

19.32 (4.96)

High School Education (%), Mean (SD)

84.63 (5.35)

85.91 (5.10)

83.60 (5.33)

NOTES: N may vary slightly across characteristics due to some missing data. 2. Column percentages may not total 100 due to rounding.
Abbreviations: CNM, Certified Nurse Midwife; DO, Doctor of Osteopathy; HIV, human immunodeficiency virus; IQR, interquartile range; NP, Nurse Practitioner; PA, Physician Assistant; PrEP,
pre-exposure prophylaxis; MD, Medical Doctor; SD, standard deviation.
a
Prescribing providers included providers who could prescribe with and without physician supervision at clinics that did not provide PrEP. Eighty-one (51.6%) could prescribe independently and
76 (48.4%) could prescribe with physician supervision.
b

Nonprescribing providers included providers who could not prescribe medications at clinics that did not provide PrEP.

c

Providers could select multiple roles.

d

In clinic catchment area.

Among nonprescribing providers, there was a significant
negative association with years worked in a clinic role
(−0.038; 95% CI, −.078 to 0.010). Among prescribing provid
ers, there were no significant covariate associations.
Attitudes Towards Pre-Exposure Prophylaxis

The mean attitudes score was 3.52 (SD = 0.55) and higher for
prescribing versus nonprescribing providers (P < .0001)
(Supplemental Table 4). However, scores on the attitudes sub
category of Acceptability of PrEP Integration in FP Settings did
not differ by prescriber status. For the attitudes subcategory of
Clinical and Socio-behavioral Attitudes towards PrEP, pre
scribing providers had more favorable attitudes than nonpre
scribing providers (P < .0001). Unadjusted associations
between provider-, clinic-, and county-level covariates and
PrEP attitudes are shown in Supplemental Table 5. In the over
all adjusted model, PrEP attitudes were positively associated
with prescribing ability (0.192; 95% CI, .071–0.313) (Figure 2,
Supplemental Table 6). Among nonprescribing providers,
there were significant positive associations with onsite insur
ance assistance (0.180; 95% CI, .021–0.340) and county HIV
prevalence (0.095; 95% CI, .004–0.186). Among prescribing
providers, there was a significant positive association with
county percentage of high school education (0.022; 95% CI,
.003–0.040).
Self-Efficacy in Pre-Exposure Prophylaxis Care

The overall mean self-efficacy score was 3.4 (SD = 0.78) and
was higher for prescribing providers versus nonprescribing
providers (P < .0001) (Table 2). When self-efficacy survey items
were grouped by the steps of PrEP care, scores were higher
among prescribing providers regarding each step (P < .0001).

Comparison of scores between steps indicated prescribing
and nonprescribing providers were most confident in PrEP
screening, less confident regarding PrEP follow up, and least
confident regarding PrEP initiation (P < .0001). Unadjusted as
sociations between provider-, clinic-, and county-level covari
ates and self-efficacy in PrEP care are shown in Supplemental
Table 7.
In the overall adjusted model, self-efficacy in PrEP care was
positively associated with prescribing ability (0.424; 95%
CI, .290–0.559), attitudes towards PrEP (0.213; 95% CI,
0.094–0.332), and contraception self-efficacy (0.439; 95%
CI, .367–0.511) and negatively associated with county per
centage Hispanic/Latinx in the population (−0.089; 95% CI,
−.162 to −0.017) (Figure 3, Supplemental Table 8). Among
prescribing providers, there were significant associations
with PrEP knowledge (0.064; 95% CI, .007–0.122), contracep
tion self-efficacy (0.459; 95% CI, .328–0.589), county percent
age uninsured (0.038; 95% CI, .011–0.065), and county
percentage Hispanic/Latinx (−0.136; 95% CI, −.236 to
−0.037). Among nonprescribing providers, there were signif
icant associations with attitudes towards PrEP (0.276; 95%
CI, .097–0.455) and contraception self-efficacy (0.435; 95%
CI, .346–0.524).
DISCUSSION

We describe Title X provider knowledge, attitudes, and selfefficacy in PrEP care in the Southern United States and associ
ations with provider-, clinic-, and county-level characteristics.
Our findings reveal gaps in FP provider knowledge, attitudes,
and confidence in certain steps of PrEP care, suggesting poten
tial avenues to tailor provider training or develop models of
PrEP care to bridge these gaps.
Bridging PrEP Provider Training Gaps • OFID • 5
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7.10 (5.60)

White Race (%), Mean (SD)

Figure 2. Linear mixed models results for attitudes towards pre-exposure prophylaxis among (A) all providers, (B) prescribing providers, and (C) nonprescribing providers.
Variables were selected for inclusion in the reduced model using a backward selection approach. Variables missing in the model results were not selected. The percentage
and prevalence variables are the percentages/numbers (log transformed where appropriate) among the county population where the provider’s clinic is located and based on
data from the US Census Bureau 2010 Census and AIDSVu. The points indicate linear mixed model estimates and whiskers indicate 95% confidence intervals. HIV, human
immunodeficiency virus.

6 • OFID • Ramakrishnan et al

Downloaded from https://academic.oup.com/ofid/article/9/11/ofac536/6761801 by Washington University in St. Louis user on 22 November 2022

Figure 1. Linear mixed models results for knowledge about pre-exposure prophylaxis among (A) all providers, (B) prescribing providers, and (C) nonprescribing providers.
Variables were selected for inclusion in the reduced model using a backward selection approach. Variables missing in the model results were not selected. The percentage
and prevalence variables are the percentages/numbers (log transformed where appropriate) among the county population where the provider’s clinic is located and based on
data from the US Census Bureau 2010 Census and AIDSVu. The points indicate linear mixed model estimates and whiskers indicate 95% confidence intervals. HIV, human
immunodeficiency virus.

Table 2. Differences in Self-Efficacy in PrEP Care Between Prescribing and Nonprescribing Providers

Provider Self-Efficacy Survey Topics and Questions

a

All Providers
N = 325 (Mean, SD)

Prescribing
Providersb
N = 149 (Mean, SD)

Nonprescribing
Providersc
N = 176 (Mean, SD)

P Valued

3.57 (.81)

3.94 (.64)

3.25 (.81)

<.0001

3.67 (0.84)

4.02 (0.66)

3.38 (0.86)

<.0001

3.46 (0.91)

3.86 (0.75)

3.12 (0.90)

<.0001

<.0001

PrEP Screening
A. Patient Engagement
HIV risk assessment per CDC PrEP guidelines
PrEP readiness assessment
PrEP adherence counseling
Patient referral to subspecialists for PrEP/HIV
B. Initial Clinical Evaluation
Test for HIV
Screen for acute HIV
Kidney function assessment
Test for and interpret active hepatitis B virus results
PrEP medication interactions assessment
PrEP Initiation

2.33 (0.95)

2.70 (1.02)

2.01 (0.76)

PrEP prescription

2.34 (1.26)

3.07 (1.31)

1.73 (0.82)

PrEP insurance navigation

2.31 (1.03)

2.32 (1.05)

2.30 (1.01)

3.29 (1.15)

3.55 (1.13)

3.07 (1.12)

<.0001

Overall PrEP self-efficacy

3.35 (0.78)

3.71 (0.66)

3.05 (0.75)

<.0001

Contraception self-efficacy

4.03 (0.92)

4.28 (0.70)

3.82 (1.03)

<.0001

PrEP Follow-up
Medication adherence counseling and side-effect assessment
Appropriate interval laboratory testing

Pregnancy intentions and contraceptive counseling initial assessment
Pregnancy intentions and contraceptive counseling follow-up
NOTES: Self-efficacy scores for each step of PrEP care represent the means of scores corresponding to questions within each step. Overall PrEP self-efficacy represents the mean of all steps
of PrEP care.
Abbreviations: CDC, Centers for Disease Control and Prevention; HIV, human immunodeficiency virus; IQR, interquartile range; PrEP, pre-exposure prophylaxis; SD, standard deviation.
a

Survey question text is abridged in this table to highlight question topic.

b

Prescribing providers included providers who could prescribe with and without physician supervision at clinics that did not provide PrEP.

c

Nonprescribing providers included providers who could not prescribe medications at clinics that did not provide PrEP.

d

P values comparing prescribing and nonprescribing provider self-efficacy scores were calculated using unpaired t tests. P values described in the manuscript text comparing self-efficacy
scores between the steps of the PrEP care were calculated using paired t tests.

In our analysis, PrEP knowledge scores were higher among
prescribing providers (those with the ability to prescribe med
ication), as expected due to differences in training and experi
ence. In addition, PrEP knowledge was negatively associated
with years worked in a clinic role, indicating that providers fur
ther out from clinical training may benefit from continuing
medical education about PrEP. Among prescribing providers,
there were no additional covariates associated with PrEP
knowledge, suggesting that tailoring the clinical content in
PrEP trainings by ability to prescribe medication may be a use
ful approach.
Although overall attitudes toward PrEP were more favorable
among prescribing providers, there was more nuance when
PrEP attitudes were subcategorized. Although both prescribing
and nonprescribing providers had favorable attitudes regarding
integration of PrEP in FP settings, nonprescribing providers
had significantly less favorable attitudes regarding the clinical
and sociobehavioral aspects of PrEP, including concerns
about PrEP efficacy, drug resistance, and risk compensation.
These findings suggest that PrEP training for nonprescribing

providers should provide content directed to overcome unfa
vorable perceptions of PrEP, particularly because more favor
able attitudes regarding an intervention can strengthen
self-efficacy [32].
Although, as expected, prescribing providers had higher selfefficacy scores compared to nonprescribing providers, both
groups were least confident in PrEP initiation compared to
the other steps of PrEP care. This finding aligns with previous
literature describing low PrEP prescription rates despite a highlevel of provider awareness and support for PrEP in the United
States [8, 33, 34]. Furthermore, other studies have suggested
that decreased knowledge about insurance navigation (a com
ponent of the PrEP initiation step) stymies providers’ ability to
prescribe PrEP [33, 35]. Lack of onsite primary care services
and lack of Medicaid expansion may exacerbate insurance nav
igation challenges and contribute to lower provider confidence
in PrEP initiation [33, 35, 36].
Our findings inform how provider training can be optimized
and tailored to improve provider knowledge, attitudes, and selfefficacy in PrEP care [8, 33]. Customized provider training has
Bridging PrEP Provider Training Gaps • OFID • 7
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PrEP side-effects counseling

been associated with effective implementation of other health
care interventions, such as improving negative attitudes towards
buprenorphine prescription for opioid use disorder [32] and fa
cilitating effective implementation of evidence-based tobacco use
treatment in health centers [37]. Emerging PrEP literature also
supports customized training; recent studies indicated the need
for (1) tailoring training to provider needs [38] and (2) provider
preferences regarding PrEP training content and format depend
ing on clinical experience [8, 33]. Other studies have shown cli
nician mentoring programs to be successful training models to
bolster the HIV workforce [39, 40]. Although various PrEP train
ing formats exist, our findings support utilizing provider-,
clinic-, and county-level characteristics and CFIR-guided assess
ments to shape trainings for specific audiences [33, 41]. Finally,
customization through a “train-the-trainer” model could be ap
plied to improve PrEP training. This model has succeeded in dis
seminating HPV vaccine education with subsequent increased
delivery and uptake of the vaccine [42]. Our findings support
use of this model because it has the potential to reach prescribing
and nonprescribing providers. Training both clinicians and staff
has been noted to improve PrEP initiation and delivery [35].
Results from our study demonstrate 3 potential paths to op
timize provider PrEP training. The first path is that of “tailored
provider training” through approaches such as addressing un
favorable provider attitudes toward PrEP, integrating PrEP
and FP training, and focusing education on the PrEP initiation
8 • OFID • Ramakrishnan et al

steps. Increased self-efficacy was associated with increased
knowledge and favorable attitudes regarding PrEP in our anal
ysis; trainings that address all 3 components may therefore im
prove provider confidence in PrEP care. In addition, because
contraception and PrEP self-efficacy were associated, future
trainings integrating clinical content about PrEP and contra
ception should be considered and may be beneficial in the con
text of long-acting PrEP and multipurpose prevention methods.
The second path for optimizing provider PrEP training is to
“target PrEP education in clinics with less support”. Onsite in
surance assistance and Medicaid expansion were associated
with more favorable PrEP attitudes, although findings were
not statistically significant in all models. Targeting clinics in ar
eas without Medicaid expansion and with less pre-existing sup
port for training clinic staff in PrEP insurance navigation and
access programs may be beneficial.
Our results also inform a third path of developing “novel mod
els of care” that can expand PrEP delivery. Given that providers
were least confident in PrEP initiation, alternative PrEP delivery
strategies, such as using telehealth or referral models for PrEP ini
tiation with existing PrEP providers, may allow providers in clin
ical settings that are new to PrEP to transition more readily from
“PrEP awareness” to “willingness to prescribe PrEP”, while main
taining longitudinal care of their patients. Such models of care may
be used as a “bridge program” for clinics until providers gain the
necessary resources and comfort to conduct PrEP initiation.
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Figure 3. Linear mixed models results for self-efficacy in pre-exposure prophylaxis (PrEP) care among (A) all providers, (B) prescribing providers, and (C) nonprescribing
providers. Variables were selected for inclusion in the reduced model using a backward selection approach. Variables missing in the model results were not selected. The
percentage and prevalence variables are the percentages/numbers (log transformed where appropriate) among the county population where the provider’s clinic is located
and based on data from the US Census Bureau 2010 Census and AIDSVu. The points indicate linear mixed model estimates and whiskers indicate 95% confidence intervals.

CONCLUSIONS

In conclusion, optimizing provider knowledge, attitudes, and selfefficacy in PrEP is an important step to successful PrEP imple
mentation in FP settings and in other clinical contexts in high
HIV burden areas. Our results indicate that training focused on
PrEP initiation for all providers in the clinical care team and alter
native models of care to support PrEP initiation may be key strat
egies to transition providers from PrEP awareness to prescription.
Our analysis also suggests that addressing provider lack of knowl
edge and concerns about PrEP may improve confidence in PrEP
care. In addition to tackling system-level challenges, future imple
mentation studies should focus on tailoring provider training and
models of care to strengthen the ability of clinics to prescribe PrEP
to improve PrEP delivery and uptake for women in the South.
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